Effect of Sex on Orthostatic Intolerance and Cardiovascular Response During Lunar Descent and Ascent

Status: Recruiting
Location: See location...
Intervention Type: Drug, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of Lunar OI (Orthostatic Intolerance) is to determine if there are differences between males and females in tolerance to and cardiovascular responses during different angles of head-up tilt simulating gravity levels less than or equal to Earth's gravity. Also, this study will determine if a gradient compression garment affects tolerance to tilting and the cardiovascular stress at different tilt angles. Males and females are being identified by biological sex. This will be a two-phased study design. In Phase I we will determine whether there are differences in the development of signs or symptoms of orthostatic intolerance between males and females when tilted head up on a table to different angles to simulate gravity levels that astronauts may experience when landing on or launching from the surface of the Moon. In Phase II, the tilt tests simulating the same gravity levels from Phase I will be repeated, but a custom-made lower-body compression garment will be worn to see if wearing the garment affects the development of orthostatic intolerance. For both study phases, before tilting, a drug will be administered to reduce the amount fluid in the blood (plasma) to levels similar to that experienced by astronauts during spaceflight.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 25
Maximum Age: 55
Healthy Volunteers: t
View:

• • Pass a test subject screening facility modified Air Force Class III physical

Locations
United States
Texas
NASA
RECRUITING
Houston
Contact Information
Primary
Jason R Lytle, PhD
jsc-cardilab@mail.nasa.gov
281-483-9531
Backup
Lucinda M Yu, MS
jsc-cardilab@mail.nasa.gov
Time Frame
Start Date: 2022-08-09
Estimated Completion Date: 2025-09
Participants
Target number of participants: 38
Treatments
No_intervention: Control
Experimental: Hypovolemic
Furosemide and potassium supplement.
Experimental: Hypovolemic plus garment
Furosemide and potassium supplement plus OIG.
Related Therapeutic Areas
Sponsors
Leads: National Aeronautics and Space Administration (NASA)

This content was sourced from clinicaltrials.gov

Similar Clinical Trials